Search - tctmd.com

Displaying 261 - 280 of 285

Sort: Relevancy | Date

Presentation

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

Presenter: Mohamed Abdel-Wahab

July 23, 2015

News Industry News

HeartWare launches European trial for next-gen MVAD heart pump

July 20, 2015

Presentation

Robotic PCI: The Future Is Here

Presenter: Giora Weisz

July 11, 2015

Presentation

Cath-Lab of The Future

Presenter: Giora Weisz

July 11, 2015

Presentation

Hazards in the Cath Lab: Is Robotic-Assited PCI the Answer?

Presenter: Ryan Reeves

July 11, 2015

News Industry News

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

July 07, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

News Industry News

Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy

June 17, 2015

News Industry News

In New Cardiac Surgery Study NephroCheck® Kidney Biomarkers Rise To The Occasion

May 29, 2015

News Daily News

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

L.A. McKeown

January 12, 2015

News Daily News

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

L.A. McKeown

January 12, 2015

News Daily News

Análisis de Gastos del ASCERT: CABG Más Caro que PCI pero con Mejores Resultados

L.A. McKeown

January 12, 2015

Presentation

Cost-Effectiveness of Revascularization Strategies: The ASCERT Study

Presenter: Zugui Zhang

January 08, 2015

News Daily News

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

August 20, 2014

News Daily News

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

L.A. McKeown

August 07, 2014

News Daily News

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

L.A. McKeown

August 07, 2014

Presentation

Practice Patterns and Clinical Outcomes After Hybrid Coronary Revascularization in the US

Presenter: R.E. Harskamp

August 01, 2014

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Conference News AHA 2012

ASCERT: CABG More Cost-Effective Than PCI Over Long Term

Jason Kahn

November 05, 2012

Presentation AHA 2012

Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery

Presenter: Eric L. Eisenstein

November 04, 2012

Advertisement

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

HeartWare launches European trial for next-gen MVAD heart pump

Robotic PCI: The Future Is Here

Cath-Lab of The Future

Hazards in the Cath Lab: Is Robotic-Assited PCI the Answer?

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy

In New Cardiac Surgery Study NephroCheck® Kidney Biomarkers Rise To The Occasion

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

Análisis de Gastos del ASCERT: CABG Más Caro que PCI pero con Mejores Resultados

Cost-Effectiveness of Revascularization Strategies: The ASCERT Study

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

Practice Patterns and Clinical Outcomes After Hybrid Coronary Revascularization in the US

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

ASCERT: CABG More Cost-Effective Than PCI Over Long Term

Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content